Partnering with MediCore as Your Nigerian Distribution Partner
Compliant, oncology-focused distribution and market-access support for international pharmaceutical manufacturers.
Why MediCore for Nigerian Market Access
Entering or expanding in the Nigerian pharmaceutical market requires a local distribution partner that understands the regulatory environment, has established relationships with healthcare providers, and operates to the compliance standards that international manufacturers expect.
MediCore was built to be that partner, specifically for oncology and specialty medicines. Our focus on a single therapeutic area means we understand the clinical context, the supply sensitivities, and the stakeholder landscape of Nigerian cancer care in a way that a general pharmaceutical distributor cannot.
We hold a PCN wholesale distribution licence, maintain alignment with NAFDAC requirements, and source exclusively from EU-GMP and WHO-GMP manufacturers. Our compliance-led approach is designed to give international manufacturers confidence that their products will be handled, stored, and distributed to the standards they require.
What MediCore Offers Manufacturers
- PCN-licensed wholesale distribution in Nigeria
- NAFDAC registration and regulatory alignment support
- Oncology and specialty medicine focus
- Established hospital and oncology centre relationships
- Pharmacist-supervised product handling
- Local market intelligence and demand assessment
- Documented compliance and quality processes
- Nigerian healthcare procurement expertise
Oncology and Specialty Focus
MediCore's exclusive focus on oncology and specialty medicines means your products are distributed by a team that understands the therapeutic area, the clinical stakeholders, and the market dynamics.
Clinical Understanding
We understand oncology treatment protocols, prescribing patterns, and the clinical urgency that drives demand for chemotherapy and specialty medicines in Nigerian hospitals.
Specialist Handling
Cytotoxic medicines, temperature-sensitive products, and high-value specialty therapies require handling standards that general distributors may not consistently meet. MediCore's operations are designed around these requirements.
Targeted Reach
Our relationships are concentrated among the hospitals, oncology centres, and specialist pharmacies that prescribe and procure oncology medicines, the facilities your products need to reach.
Compliance-Led Approach
We understand that international manufacturers need assurance that their products will be handled in compliance with agreed standards. MediCore's compliance framework is designed to provide that assurance.
- PCN wholesale distribution licence with regular regulatory inspections
- Documented quality management processes
- Pharmacist-supervised receiving, storage, and dispatch
- Full batch-level traceability from receipt to delivery
- Cytotoxic handling SOPs aligned to safety requirements
- Temperature monitoring where required
- Adverse event reporting and recall procedures
- Regular compliance review and continuous improvement
What a Partnership Involves
A distribution partnership with MediCore typically involves the following stages:
1. Initial Discussion
We begin with a confidential discussion about your products, your objectives for the Nigerian market, and your requirements from a distribution partner. This allows both parties to assess alignment before committing resources.
2. Market and Regulatory Assessment
MediCore provides an assessment of the Nigerian market opportunity for your products, including demand potential, competitive landscape, pricing considerations, and NAFDAC registration pathway.
3. Agreement and Onboarding
We establish a formal distribution agreement covering product scope, territories, compliance responsibilities, pricing, and supply terms. Both parties complete due diligence before commercial activities begin.
4. Launch and Ongoing Support
MediCore manages in-market distribution, hospital and pharmacy engagement, supply coordination, and ongoing commercial support. Regular reporting keeps manufacturers informed of market performance and supply status.
Explore a Distribution Partnership
If you are an international pharmaceutical manufacturer interested in discussing distribution of your oncology products in Nigeria, we welcome your enquiry.